Melorich Australian Multigenerational Labradoodles


The adult tick seeks a larger host, hence its name “the deer tick;” however, with man encroaching upon the range of the deer, there are often plenty of dogs or humans for the tick to attack. The adult ticks mate on their new host, feed, and transmit the Lyme spirochete if they are carrying it. The male tick remains attached through the winter but the female, once engorged with the host’s blood, drops off, hides under leaves and other debris through the winter, and lays her eggs in the spring for the two-year cycle to begin again.

The feeding tick is basically a blood-sucker. It must keep its host’s blood from clotting in order to continue sucking so it is able to regurgitate assorted enzymes to keep the blood flow liquid and smooth. It is during this regurgitation process that the Lyme spirochete is brought up from the tick’s mid-gut to its mouth parts.

This process requires a minimum of 48 hours which means
that if the tick is removed within 48 hours of attachment,
the spirochete cannot be transmitted and the host will not get the disease.

Tick control on the host is an effective means of infection prevention. There are several effective tick control products available including: the Preventic collar, Advantix, Frontline, Vectra 3D and Promeris Canine. All of these products either kill the tick or cause it to drop off prior to the 48 hour deadline.

Preventic collar Advantix red Frontline Plus 44
vectra Promeris large dog

On the west coast of the United States, there is far less Lyme disease than in the east, although the northern coast of California is considered to have moderate risk. This is because the Lyme vector in these areas is primarily Oxides pacificus, a tick that strongly prefers to feed on reptiles rather than mammals. Reptile blood has natural anti-Borrelia factors which kill the Lyme spirochete and prevent further transmission. 

The CDC (Center for Disease Control) provides a map, below, of the U.S. indicating risk.

Map: National Lyme disease risk map with four categories of risk

There are several subspecies of Borrelia burgdorferi in different parts of the world so “Lyme disease” is not unique to the United States.


The spirochete that causes Lyme disease cannot live outside the body of a host. It must live within either a mammal or a tick.

In the mammal’s body, the spirochete is especially adept at binding to connective tissue. If one is doing additional reading on this organism, one will encounter references to the spirochete’s surface proteins called “Osp’s” (“Osp” stands for “outer surface protein”). Different Osp’s are expressed depending on whether the spirochete is attached to the tick midgut (OspA), the mammal’s connective tissue (OspC), or whether the tick is in an early or late stage of mammal infection (Osps E and F respectively). By modifying its Osp’s, the spirochete is able to change its presentation to the mammalian host’s immune system thus escaping immune destruction. In addition to changing Osp’s, the spirochete can change its shape into at least 3 different forms and is able to hide within cellular folds. (The Lyme spirochete is a master of disguise and camouflage.)

This presents an enormous diagnostic challenge:
 if the host’s immune system can’t even find the organism,
how are we supposed to detect it?


A dog with symptoms of Lyme disease ideally should have a test to confirm or rule out Lyme disease. Since it is almost impossible to culture the Lyme spirochete, efforts have centered on detection of antibodies against the Osp’s. Here are the problems encountered with this method:

In a Lyme endemic area, as many as 90% of the dogs will have antibodies against the Lyme spirochete. Most exposed dogs never get sick but almost all of them will develop antibodies and these antibodies persist for years. How do we tell the dogs that have active infection from those that have been exposed and are not sick from their exposure?
Vaccine has been available for Lyme disease for a decade or more. How do we distinguish antibodies generated by the vaccine from those generate by natural infection?
How do we distinguish antibodies generated by similar organisms (Leptospira, for example, or harmless other Borrelia species)?

3Dx Kit ShotThe solution to these problems has come about only recently in the form of the “C6 test.” This is an immunological test for antibody against the “C6 peptide,” a very unique section of the one of the Borrelia burgdorgeri surface antigens. As the spirochete changes its configuration to escape the host’s immune system, the C6 peptide remains constant and always detectable. Vaccine does not contain the C6 peptide so vaccinated dogs will not test positive. Dogs with other infections will not erroneously test positive. Further, this test is simple enough to be available as an in-house test kit (the IDEXX “Snap-3 Dx test” or “Snap-4 Dx test”) which can be run in most veterinary hospitals, with results in approximately 10 minutes.

This still does not address distinguishing active infection from exposure. Dogs will test C6 positive within 3-5 weeks of infection. They stay positive for over a year.


Which of these dogs get sick and which ones do not? Does the dog with joint pain, fever, and a positive C6 test need medication? This is where the news is particularly good.

Treatment of Lyme disease utilizes a 2-4 week course of doxycycline a medication which is inexpensive and has limited side effects potential. Amoxicillin is another effective alternative, also inexpensive and with minimal side effects. If Lyme disease is a consideration, many veterinarians simply prescribe the medication. Obvious improvement is seen within 48 hours. Further, most tick-borne infections capable of causing joint pain, fever, and signs similar to Lyme disease generally all share doxycycline responsiveness so a simple course of medication actually covers several types of infection.

Eradication of the Lyme spirochete is not a reasonable expectation with treatment; the organism is simply too good at hiding. The goal instead is to bring the patient into what is called a “premunitive state.” This is the state that 90% of infected dogs achieve when they get infected but never get ill: the organism is in their bodies latently but is not causing active infection.


Some dogs are in fact harmed by the long time presence of an infectious organism in their bodies. The immune system is constantly active in its attempt to remove the invading spirochete and over the years these complexes of antibodies may deposit in the kidney and cause damage. It has been recommended that dogs with positive Borrelia burgdorferi antibody levels be regularly screened for significant protein loss in their urine with a test called a “urine protein to creatinine ratio.” This group of dogs may require medication for their kidney disease.

Recently an especially sensitive test has been developed for the detection of minute quantities of blood proteins in the urine. This test, called the Erd test, is so sensitive that its use is not yet determined (i.e. at what point is albumin loss in the kidney significant and under what circumstances might some albumin loss be normal and expected?).


Vaccine prevents infection in dogs vaccinated before any exposure to Lyme spirochetes. This means it is only helpful for dogs not yet exposed such as puppies and dogs from non-endemic areas travelling to endemic areas. Annual boosters continue the vaccine-based immunity.Merial Lyme Vaccine

Ft Dodge lymevaxThere are two types of vaccine available: the killed whole spirochete vaccine (Fort Dodge’s vaccine) where basically intact dead spirochetes are injected into the host. By using the entire spirochete, the host is exposed to parts of the organism that are not useful in immunization and may lead to vaccine reaction. The other type of vaccine is felt to be superior in preventive reactions and that is the recombinant vaccine (Merial’s vaccine). This vaccine generates antibodies specifically against OspA, the surface protein the spirochete uses to attach to its tick host. When the tick bites and sucks blood full of Anti-OspA antibodies, the spirochete’s migration sequence is blocked and the spirochete is prevented from even exiting the tick. The vaccine utilizes DNA for OspA cloned into a harmless virus so that the entire Lyme spirochete is not used; only the OspA DNA is used.

Vaccination against the Lyme organism remains controversial. We will present both sides of the argument and the pet owner can decide if they want to include vaccination in their Lyme prevention efforts.

Argument Against Vaccination

Lyme disease in the dog is an infection for which over 90% of infected dogs will never get sick and the 5-10% that do get sick can be easily treated with a safe inexpensive course of antibiotics. This situation would seem to indicate that vaccination is simply not worth the expense.
As for the kidney disease that can occur in some individuals with long term antigen exposure: we do not know what Borrelia antigens are involved in the immune stimulation that causes this condition. It might be that the same antigens used in the vaccines are involved in which case vaccination might be just as hazardous as actual infection. Even OspA, the same antigen of the recombinant vaccine, has been implicated in chronic human disease.

Argument For Vaccination

We vaccinate ourselves for the flu, an infection that is for most people more of a nuisance than a
life-threatening event, and think nothing of it. Vaccination is about prevention of infection; just because an illness is not life-threatening does not mean that we should not prevent it with vaccine. Further, in a
non-endemic area, Lyme disease is not going to be a cause of arthritis that most veterinarians will consider. Treatment is only simple if one thinks to perform the treatment but in an area where there is very little Lyme disease, this treatment may easily be omitted. Why not just prevent the infection outright from the beginning if the dog is going to travel to a tick endemic area?
If we allow our dogs to readily become infected with the Lyme organism, do they not become a potential source for human infection (through their ticks)? We try to minimize the deer and mice in our vicinity but we want to keep company with the family dog but who wants a reservoir of Lyme spirochete in their home?
As for the kidney disease, we do not know what spirochete antigens are implicated in this condition. The recombinant vaccine exposes the patient only to one spirochete antigen (OspA) and prevents the introduction of the spirochete into the mammal’s body. Vaccination, at least with the recombinant vaccine, may be preventive to this syndrome.

Again, when it comes to prevention, there is nothing controversial about tick control.
It is crucial in Lyme endemic areas to use tick controlling products.

Lyme disease is a regional problem. For more guidance regarding this infection in your area or areas where you will be travelling, see your veterinarian.